Business

Wegovy maker warns of 'painful' price cuts as shares plunge

Published

on

Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version